Tag archive for ‘Ondexxya EU conditional approval’
Ondexxya Receives Conditional EU Approval as Expected (PTLA, Buy, $36.44)
Portola Pharmaceuticals announced last Friday that the European Commission granted conditional Marketing Authorization for Ondexxya (andexanet alfa). In the US, the product is called Andexxa; it was approved in May 2018. In March, 2019 management said that it expected this EU approval in May. As in the US, the approval was conditional and was based […]